Cleveland Clinic’s Liver Cancer Program includes hepatologists, radiologists, oncologists, liver and transplant surgeons, and specialized nurse coordinators – working together as a team. One call puts you in touch with our multidisciplinary team that works with patients who have benign liver tumors, cancerous liver tumors, cirrhosis of the liver and more in order to develop the appropriate treatment plan, aimed at preserving liver function and quality of life.
This new, “one-stop” clinic improves your treatment by eliminating multiple appointments with different physicians at various locations. Now, all of the doctors you need are assembled here under one roof for you. Not only is this model of care more convenient, but it also allows our physicians to create an individualized treatment plan that’s best for you in less than 30 days.
Mission of the Liver Cancer Program
The mission of the Liver Cancer Program is to offer state of the art medical care to patients with hepatic tumors through a multidisciplinary team of experienced health care professional leaders in the field of hepatic oncology.
Philanthropic support provides the necessary resources to continue cutting-edge research.
To make an appointment, call 216.445.8389 or 800.223.2273 ext. 58389.
What We Treat
Primary Malignant Tumors
Secondary Malignant Tumors
- Colorectal metastatic liver disease
- Neuroendocrine tumors
- All other metastatic hepatic diseases
At Cleveland Clinic, advanced and diverse surgical techniques and medical oncological therapies are applied to treat complex tumors affecting the liver including:
Up to 70% of the liver volume can be removed if needed. Occasionally, future liver remnant (FLR) volume calculated via computed tomography (CT) or magnetic resonance imaging (MRI) is insufficient. Portal vein embolization is then indicated to achieve growth of the FLR volume. Typically, liver growth after portal vein embolization takes about 4 to 6 weeks. Before proceeding with extended hepatectomy a repeat CT or MRI is obtained for reassessment of liver volume.
ALPPS Procedure (Associating liver partition and portal vein ligation for staged hepatectomy)
ALPPS procedure is a two stage hepatectomy in which during the first stage the portal vein branch to the liver lobe less affected by tumor is ligated and the liver parenchyma is divided so volume growth of the FLR is enhanced and achieved faster compared to traditional two stage hepatectomy.
When multiple tumors affect both lobes of the liver a two stage hepatectomy is often needed. During the first stage hepatectomy the lobe of the liver less affected by tumor is treated. Portal vein embolization follows this first operation to achieve enough volume of the cleared liver lobe. The second stage hepatectomy is performed after an interval of 4 to 6 weeks to remove the liver lobe most affected by tumor burden.
When tumors compromise large vascular structures of the liver, occasionally ex-vivo hepatectomy is needed. Through this approach the liver is explanted from the patient and the tumor is removed and vascular reconstructions needed performed. This technique allows easier and faster removal of the tumor and causing less blood loss. Once the liver is cleared from tumor, is re-implanted back into the patient.
Hepatic Artery Chemo-infusion (HAI) Through a Surgically Implantable Pump
- Mostly implemented for advanced colorectal cancer liver metastasis (CRLM), HAI is a liver directed therapy through which chemotherapy is infused through a titanium implantable pump that has a catheter that is inserted in the hepatic artery
- Advantage of this form of chemotherapy is that it can be more effective and with less side effects compared to systemic chemotherapy
- Studies have shown that use of HAI prolonged patient survival when compared to patients in whom HAI was not implemented
Advanced Laparoscopic Liver Surgery
- Minimally invasive liver surgery has evolved significantly. Its advantage is that post-operative recovery is faster and with less pain. Studies have shown that in selected patients no difference in oncologic outcome has been noticed when compared with traditional open surgery
- At Cleveland Clinic, state of the art laparoscopic liver surgery is offered to selected patients with various liver tumors
- Liver transplant is the surgery of choice for patients with cirrhosis and liver tumors. Selected patients with hepatocellular carcinoma, cholangiocarcinoma and liver metastasis from colorectal cancer can be considered for liver transplantation
- Liver transplantation using living donors offered at Cleveland Clinic is also an advanced and unique alternative treatment for patients with liver tumors
Locoregional Therapies (LRT)
LRT are non-surgical interventions performed by the interventional radiologist, to achieve total tumor destruction or to downsize the tumor
- Stereotactic beam radiation therapy (SBRT)
- Microwave ablation
Medical Oncology Treatments
- Diverse systemic chemotherapies and molecular targeted therapies
For Additional Information
Appointments & Locations
To schedule an appointment with a Cleveland Clinic liver cancer specialist, please call 216.445.8389.
Videos show graphic content. Please watch at your own disgression.
Support & Services
In addition to offering state of the art diagnostic techniques and liver cancer treatment methods, our specialists also offer an array of resources that can help patients cope with the demands of cancer. Patients are encouraged to take advantage of these resources to ease the burden of managing cancer.
Clinical Trials & Research
The goal of our research program is to advance the knowledge on biology of liver, biliary and pancreas malignancy towards personalized medicine, best utilization of current therapies, and therapy discovery.
Through the Cleveland Clinic Cancer Program, patients’ bio-specimens including blood, breath exudate and liver tumor tissue are collected and bio-banked for research purposes. This process is initiated after informed consent is obtained from the patient at the liver tumor clinic.
Innovation and treatment discoveries are pivotal within the mission of the Cleveland Clinic Liver Cancer Program. Some of these endeavors include:
- 3-D printing of liver models and computer software to aid surgical treatments of complex liver malignancies
- Tissue, serum and breath bio-repository for translational research
- Liver malignancy mice xenograft research platform—to study liver tumors from individual patients fostering personalized medicine in the field of liver oncology
Cleveland Clinic Cancer Center clinical trials offer patients important treatment options and access to the latest treatments and procedures resulting from cancer research.
Cleveland Clinic Cancer Center is committed to working with you to provide the best care for your patients. Our team is also dedicated to the training and education of medical professionals to advance cancer care and research.